Correction: Integration of metabolites from meta-analysis with transcriptome reveals enhanced SPHK1 in PDAC with a background of pancreatitis

Correction: Integration of metabolites from meta-analysis with transcriptome reveals enhanced SPHK1 in PDAC with a background of pancreatitis

Bibliographic Details
Main Authors:	Vijayasarathy Ketavarapu, Vishnubhotla Ravikanth, Mitnala Sasikala, G. V. Rao, Ch. Venkataramana Devi, Prabhakar Sripadi, Murali Satyanarayana Bethu, Ramars Amanchy, H. V. V. Murthy, Stephen J. Pandol, D. Nageshwar Reddy
Format:	Article
Language:	English
Published:	BMC 2022-07-01
Series:	BMC Cancer
Online Access:	https://doi.org/10.1186/s12885-022-09920-7

Similar Items

Endophytic Fungi as Novel Resources of natural Therapeutics
by: Maheshwari Rajamanikyam, et al.
Published: (2017-08-01)

An insight to PDAC tumor heterogeneity across pancreatic subregions using computed tomography images
by: Sehrish Javed, et al.
Published: (2024-11-01)

Heterologous Booster Dose with CORBEVAX following Primary Vaccination with COVISHIELD Enhances Protection against SARS-CoV-2
by: Shashidhar Jaggaiahgari, et al.
Published: (2022-12-01)

Role of SphK/S1P in cardiovascular diseases
by: TANG Lihong, CHEN Chunling
Published: (2024-08-01)

Imaging p53 in Pancreatic Ductal Adenocarcinoma (PDAC)
by: Koustoulidou, S, et al.
Published: (2016)

Syntheses of Hydrazino-and Azo-Sphingosine Derivatives and Their Evaluation as SphK Inhibitors
by: Yolanda Díaz, et al.
Published: (2019-09-01)

Design, Synthesis and Biological Activity Testing of Library of Sphk1 Inhibitors
by: Shuangshuang Geng, et al.
Published: (2022-03-01)

Differential DNA hydroxy/methylation analyses for improving prognostic accuracy in localised PDAC and a better understanding of PDAC progression
by: Yau, A
Published: (2023)

Role of microbiota and microbiota‐derived short‐chain fatty acids in PDAC
by: Hülya Yılmaz Temel, et al.
Published: (2023-03-01)

ATF3 regulates SPHK1 in cardiomyocyte injury via endoplasmic reticulum stress
by: Huiling Chen, et al.
Published: (2023-09-01)

HOXC11 drives lung adenocarcinoma progression through transcriptional regulation of SPHK1
by: Xin Peng, et al.
Published: (2023-02-01)

Clinical relevance of CERK and SPHK1 in breast cancer and their association with metastasis and drug resistance
by: Priyanka Bhadwal, et al.
Published: (2022-10-01)

Activation of SphK1 by adipocytes mediates epithelial ovarian cancer cell proliferation
by: Lan Dai, et al.
Published: (2021-05-01)

Biological Hallmarks and New Therapeutic Approaches for the Treatment of PDAC
by: Graziana Digiacomo, et al.
Published: (2021-08-01)

Exploring the therapeutic potential of triterpenoid saponins from Gymnema sylvestre: Mechanistic insights into hepatoprotection, immunomodulation, anticancer activities, molecular docking, and pharmacokinetics
by: Vasudeva Reddy Netala, et al.
Published: (2024-12-01)

Metavert synergises with standard cytotoxics in human PDAC organoids and is associated with transcriptomic signatures of therapeutic response
by: Jingyu An, et al.
Published: (2024-11-01)

RNA干扰下调SPHK1基因表达抑制胃癌细胞增殖
Published: (2013-01-01)

SPHK1‐induced autophagy in peritoneal mesothelial cell enhances gastric cancer peritoneal dissemination
by: Songcheng Yin, et al.
Published: (2019-04-01)

The impacts of SphK1 on inflammatory response and oxidative stress in LPS-induced ALI/ARDS
by: Wei Chao-shun, et al.
Published: (2023-02-01)

Targeting SphK1/2 by SKI-178 inhibits prostate cancer cell growth
by: Lu Jin, et al.
Published: (2023-08-01)

Cellular collusion: cracking the code of immunosuppression and chemo resistance in PDAC
by: Chiara Musiu, et al.
Published: (2024-05-01)

Clinically impactful metabolic subtypes of pancreatic ductal adenocarcinoma (PDAC)
by: Jannat Pervin, et al.
Published: (2023-10-01)

An integrated study to decipher immunosuppressive cellular communication in the PDAC environment
by: Gülben AVŞAR, et al.
Published: (2023-11-01)

Mutant SF3B1 promotes malignancy in PDAC
by: Patrik Simmler, et al.
Published: (2023-10-01)

Whole-body bioluminescence imaging of T-cell response in PDAC models
by: Roisin McMorrow, et al.
Published: (2023-07-01)

Disruption of Broad Epigenetic Domains in PDAC Cells by HAT Inhibitors
by: Diana L. Gerrard, et al.
Published: (2019-06-01)

Adult Pancreatoblastoma: Clinical Insights and Outcomes Compared to Pancreatic Ductal Adenocarcinoma (PDAC)
by: Han Yin, et al.
Published: (2024-08-01)

Circulating Tumor Cell Subpopulations Predict Treatment Outcome in Pancreatic Ductal Adenocarcinoma (PDAC) Patients
by: Ian M. Freed, et al.
Published: (2023-09-01)

Sphk1 regulates HMGB1 via HDAC4 and mediates epithelial pyroptosis in allergic rhinitis
by: Wei Huang, MM, et al.
Published: (2024-09-01)

Micro- and nano-scale polymer-on-polymer stamping of the polyelectrolytes SPS and PDAC
by: Gourdin, Shoshana Ruth, 1977-
Published: (2005)

Integrated analysis of microbiome and metabolome reveals signatures in PDAC tumorigenesis and prognosis
by: Yuan Fang, et al.
Published: (2024-11-01)

Overcoming immunotherapeutic resistance in PDAC: SIRPα-CD47 blockade
by: Abdullahi Alausa, et al.
Published: (2022-07-01)

Mitochondrial Metabolism in PDAC: From Better Knowledge to New Targeting Strategies
by: Gabriela Reyes-Castellanos, et al.
Published: (2020-08-01)

Complement and Fungal Dysbiosis as Prognostic Markers and Potential Targets in PDAC Treatment
by: Cornelia Speth, et al.
Published: (2022-12-01)

Regulatory role of RNA modifications in the treatment of pancreatic ductal adenocarcinoma (PDAC)
by: Hao Chen, et al.
Published: (2023-11-01)

Prognostic value of KRAS subtype in patients with PDAC undergoing radical resection
by: Manxiong Dai, et al.
Published: (2022-12-01)

Triggering of endoplasmic reticulum stress via ATF4-SPHK1 signaling promotes glioblastoma invasion and chemoresistance
by: Beiwu Lan, et al.
Published: (2024-08-01)

Lathyrol reduces the RCC invasion and incidence of EMT via affecting the expression of AR and SPHK2 in RCC mice
by: Shengyou Song, et al.
Published: (2024-07-01)

The emerging roles of sphingosine 1-phosphate and SphK1 in cancer resistance: a promising therapeutic target
by: Samar Sami Alkafaas, et al.
Published: (2024-02-01)

Synthesis, glycosidase inhibitory activity and computational studies of dideoxymethylnojirimycin and its derivatives
by: Jattuboyina Siva Krishna, et al.
Published: (2023-12-01)